PHOTO
Manama, Bahrain: The Managing Director of Bahrain Specialist Hospital, Dr. Kasim Ardati, has stated that with the support of the Apollo Group of Hospitals in India and BSH’s foresight to be in line with the leadership’s vision for the Kingdom of Bahrain amidst talk of health tourism in the region - they have successfully operated BSH Apollo Heart Center with its private catheterization lab for one year. This has ensured that the community can access world-class healthcare, particularly for cardiac-related cases, despite travel restrictions around the world in the circumstances of the present pandemic.
“Over the past 1 year, it has become increasingly obvious just how much effort has been expended in ensuring that the resilience of the country’s healthcare infrastructure stands strong even in the face of a global pandemic such as COVID-19,” Dr. Kasim said.
Dr. Kasim made the comments on the occasion of the 1 year anniversary of the BSH Apollo Heart Center’s Cardiac Catheterization laboratory, the first of its kind in the private sector.
The project, launched in a bid to support Bahrain’s endeavor to become a hub for medical tourism in the region, is a collaboration between Bahrain Specialist Hospital and Apollo Hospitals, which annually treats more than 60,000 GCC citizens in India.
He further added, “The Cath Lab was launched just as COVID-19 was beginning to become a serious global concern. We are happy to have been able to contribute towards ensuring that there is no disruption to the healthcare of the most vulnerable in our community. ”
“Now that COVID-19’s long term of effects on heart health are becoming increasingly clear, it has become all the more important to monitor, treat and manage heart conditions as rapidly as possible; the safety protocols we have established at the Cath Lab allow us to do just that, while maintaining high levels of infection control,” added Dr Abdul Azeez Asad Mohammed, Interventional Cardiologist who spearheads the Cardiac Catheterization Lab.
The BSH Apollo Heart Center’s Cath Lab has so far witnessed over 150 procedures and, with the BSH Apollo Heart Center cardiologists having provided care to over 3,500 heart patients.
The Cath Lab has also achieved a number of milestones over the past year, particularly the reduction in door-to-balloon time for acute heart attack to an average of 42 minutes as compared to the world standard of 90 minutes.
As part of the anniversary celebration, Bahrain Specialist Hospital held a digital forum, Health Vision 2030, with international speakers from 5 institutions spanning 3 countries. This is the second iteration of the annual event, with this year’s topic being “Management of Acute Myocardial Infarction: STEMI and NON-STEMI”.
-Ends-
ABOUT BAHRAIN SPECIALIST HOSPITAL
Bahrain Specialist Hospital (BSH) stands as a center of excellence in the Arabian Gulf. It is a highly specialized Medical Center that provides up to date medical services by experienced Consultants and Specialists, using the latest technologies with the-state-of-the-art medical equipment and systems. BSH is housed in purposely-designed modern premises and is the first hospital in Bahrain that availed the Joint Commission International accreditation (JCI) and the only private healthcare facility that was inaugurated by HM King Hamad Bin Salman Al Khalifa, the ruler of Bahrain.
For media enquiries, please contact:
Obai & Hill
Design and PR Agency
www.obaiandhill.com
Shreya Rammohan
shreya@obaiandhill.com
© Press Release 2020
Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.
